866-997-4948(US-Canada Toll Free)

Endometriosis Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 192 Pages

Endometriosis Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Endometriosis Global Clinical Trials Review, H2, 2017" provides an overview of Endometriosis clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Endometriosis to Women's Health Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Endometriosis to Women's Health Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Endometriosis Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Endometriosis 33
Jul 24, 2017: Evotec and Bayer Advance Endometriosis Programme into Phase I Clinical Development and Extend Alliance 33
Jun 29, 2017: Myovant Sciences Initiates Phase 3 Clinical Program of Relugolix in Women with Endometriosis-Associated Pain 33
Jun 07, 2017: ObsEva Announces the Completion of a Phase 1 PK/PD Clinical Trial Evaluating Different Doses of OBE2109 and Add-Back Therapy 34
May 24, 2017: Myovant Sciences Announces Presentation of Data at the European Congress of Endocrinology from Phase 2 Extension Study Evaluating Relugolix in Women with Endometriosis-Associated Pain 34
May 19, 2017: Myovant Sciences Announces Presentation of Positive Phase 2 Data for Relugolix in Women with Endometriosis-Associated Pain at the World Congress on Endometriosis 35
May 18, 2017: Myovant Sciences Announces Upcoming Presentations of Relugolix Data from Phase 2 Trial in Women with Endometriosis-Associated Pain 36
May 17, 2017: AbbVie Presents Pivotal Phase 3 Data on Investigational Treatment Elagolix at the World Congress on Endometriosis 36
Clinical Trial Profile Snapshots 38
Appendix 191
Abbreviations 191
Definitions 191
Research Methodology 192
Secondary Research 192
About GlobalData 193
Contact Us 193
ource 193

List of Tables
Endometriosis Therapeutics, Global, Clinical Trials by Region, 2017* 8
Endometriosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Endometriosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Endometriosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Endometriosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Endometriosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Endometriosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Endometriosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
Proportion of Endometriosis to Women's Health Clinical Trials, G7 Countries (%), 2017* 16
Endometriosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Endometriosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Endometriosis to Women's Health Clinical Trials, E7 Countries (%), 2017* 19
Endometriosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Endometriosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Endometriosis Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Endometriosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Endometriosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Endometriosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Endometriosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Endometriosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Endometriosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Endometriosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Endometriosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures
Endometriosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Endometriosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Endometriosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Endometriosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Endometriosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Endometriosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Endometriosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Endometriosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
Proportion of Endometriosis to Women's Health Clinical Trials, G7 Countries (%), 2017* 16
Endometriosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Endometriosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Endometriosis to Women's Health Clinical Trials, E7 Countries (%), 2017* 19
Endometriosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Endometriosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Endometriosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Endometriosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Endometriosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Endometriosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Endometriosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Endometriosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Endometriosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Endometriosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Endometriosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
GlobalData Methodology 192

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *